Newsroom
Sorted by: Latest
-
Viridian Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Business Progress
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today reported financial results and recent business updates for the third quarter ended September 30, 2026. "We are highly encouraged by the strength of Lumvoa's early launch in TED, which has exceeded expectations," said Steve Mahoney, President and Chief Executive Offi...
-
The Kraft Heinz Company Declares Regular Quarterly Dividend of $0.40 Per Share
PITTSBURGH & CHICAGO--(BUSINESS WIRE)--The Kraft Heinz Company (NYSE: KHC) announced today that the Company’s Board of Directors declared a regular quarterly dividend of $0.40 per share of common stock payable on December 23, 2026, to stockholders of record as of December 4, 2026. ABOUT THE KRAFT HEINZ COMPANY Kraft Heinz (NYSE: KHC) is one of the world’s largest food and beverage companies, with approximately $25 billion in net sales in 2025 and a portfolio of iconic brands enjoyed by consumer...
-
Capra Bank and Zact Expand Partnership to Drive Commercial Banking Growth
DUBUQUE, Iowa & SUNNYVALE, Calif.--(BUSINESS WIRE)--Zact announces a strategic partnership with Capra Bank to launch Capra SpendLink, expanding digital capabilities for Capra's commercial customers...
-
CDW Reports Third Quarter 2026 Earnings
VERNON HILLS, Ill.--(BUSINESS WIRE)--CDW Corporation (Nasdaq: CDW): (Dollars in millions, except per share amounts) Three Months Ended September 30, Nine Months Ended September 30, 2026 2025 Percent Change 2026 2025 Percent Change Net sales $ 6,754.5 $ 5,737.4 17.7 % $ 19,006.5 $ 16,913.1 12.4 % Gross profit $ 1,385.3 $ 1,255.5 10.3 $ 3,895.1 $ 3,619.0 7.6 Gross profit margin 20.5 % 21.9 % 20.5 % 21.4 % Operating income $ 489.5 $ 443.3 10.4 ...
-
Kraft Heinz Reports Third Quarter 2026 Results; Updates 2026 Full Year Outlook
PITTSBURGH & CHICAGO--(BUSINESS WIRE)--The Kraft Heinz Company (NYSE: KHC) (“Kraft Heinz” or the “Company”) today reported financial results for the third quarter of 2026. “Our 2026 operating plan to turn around the U.S. business and accelerate growth internationally is on track,” said Steve Cahillane, CEO of Kraft Heinz. “Relative to last year, our market share, sales, and volume trends are improving in every region. We are increasingly meeting consumers where they are, and giving them more re...
-
Olympus Cosmetic Group to Deploy AI Med Consult Across Its Practices
ST. PETERSBURG, Fla.--(BUSINESS WIRE)--Olympus Cosmetic Group, a surgeon-led partnership platform purpose-built for leading aesthetic surgery practices, has signed an agreement with AI Med Consult to introduce its AI-powered patient engagement technology across its growing network of 18 locations. The partnership supports Olympus' commitment to equipping surgeon partners with innovative resources that enhance patient experience, strengthen practice operations, and support long-term growth. “We’...
-
Marriott Vacations Worldwide Reports Third Quarter 2026 Financial Results
ORLANDO, Fla.--(BUSINESS WIRE)--Marriott Vacations Worldwide Corporation (NYSE: VAC) (“MVW,” the “Company,” “we” or “our”) reported financial results for the third quarter of 2026. Third Quarter 2026 Highlights Contract sales increased 29% year over year to $565 million in the quarter. VPG was $4,822, 30% above last year. Development profit increased 97% to $142 million versus the prior year. Net income attributable to common stockholders was $82 million compared to net loss attributable to com...
-
Definium Therapeutics Presents Topline Phase 3 Data for DT120 ODT in Generalized Anxiety Disorder and Major Depressive Disorder at 2026 NEI Fall Congress
NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced four poster presentations at the 2026 NEI Fall Congress taking place November 5 through 8 in Colorado Springs, CO. Positive topline results from Panorama, the Company’s second Phase 3 study of DT120 (lysergide...
-
Assured Guaranty Ltd. Declares Quarterly Dividend of $0.38 per Common Share
HAMILTON, Bermuda--(BUSINESS WIRE)--Assured Guaranty Ltd. (NYSE:AGO) today declared a quarterly dividend of $0.38 per common share. The dividend is payable on December 2, 2026 to shareholders of record at the close of business on November 18, 2026.Assured Guaranty Ltd. is a publicly traded (NYSE: AGO), Bermuda-based holding company. Through its subsidiaries, Assured Guaranty provides credit enhancement products to the U.S. and non-U.S. public finance, infrastructure and structured finance market...
-
Smith Douglas Homes Reports Third Quarter 2026 Results
ATLANTA--(BUSINESS WIRE)--Smith Douglas Homes Corp. (NYSE: SDHC) (“Smith Douglas” or the “Company”) today announced third quarter results for the three and nine months ended September 30, 2026. Q3 2026 Results as compared to Q3 2025: Home closings increased 5% to 831 Home closing revenue increased 0.2% to $262.5 million Home closing gross margin of 16.3% compared to 21.0% Net new home orders increased 13% to 777 Backlog homes increased 25% to 947 Pretax income of $3.3 million compared to $17.2...